Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Flex Pharma (NASDAQ:FLKS) shares are trading lower after the company announced more shareholder votes are required to complete its merger with Salarius Pharma despite “overwhelming support.”
According to Flex Pharma, additional shares must be voted in order to complete the planned merger with Salarius Pharmaceuticals, an epigenetic oncology company.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Flex Pharma has also adjourned the special meeting until July 12 in order to provide shareholders with more time to complete proxies and vote their shares.
“We are very pleased that the vast majority of shareholders who voted support the merger with Salarius, consistent with the recommendations of both leading, independent proxy advisory services ISS and Glass-Lewis,” said Flex Pharma CEO William McVicar.
Flex Pharma traded down 26.6% to 47 cents per share.
Related Links:
Aclaris Announces Positive Results From Alopecia Treatment Trial
Pfizer To Buy Array Pharma For $48/Share
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.